ZIOP Profile
ZIOPHARM Oncology Inc. (ZIOP) is a biopharmaceutical company that develops gene and cell therapies for the treatment of cancer. The company's focus is on developing therapies that activate and enhance the body's immune system to fight cancer. ZIOPHARM's pipeline includes several clinical-stage programs that target a variety of cancer types, including solid tumors and blood cancers.
ZIOPHARM Oncology was founded in 2005 and is headquartered in Boston, Massachusetts. The company has collaborations with several academic institutions and other biopharmaceutical companies to advance its research and development efforts.
As of February 2023, ZIOPHARM Oncology Inc. is still an active publicly traded company listed on the NASDAQ stock exchange under the ticker symbol ZIOP. The company has experienced ups and downs in its stock price over the years, driven by clinical trial results and other news related to its research and development efforts.
|
